| Application no. and date | 09733923.8 (espacenet) (Federated) (European Patent Register), 20090423 | | Patent/reg. no. and date | DK/EP 2291380, 20110907 | | Publication date | 20110309 | | Priority no. and date | EP 08155094, 20080424 | | EP pub. no. and date |
EP 2291380 20110309 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica N.V., Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | JAN PRD2965 | | Inventor | GUILLAUME, Michel, Joseph, Maurice, André, Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE,
GAEKENS, Tim, Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE | | Representative | | | Opponent | | | IPC Class | A61K 31/485 (2006.01) , A61P 25/30 (2006.01) , C07D 489/08 (2006.01) | | Title | Nalmefen-prodrugs | | Int. application no. | EP2009054882 | | Int. publication no. | WO2009130272 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
